The implications of the Supreme Court's decision on abortion for patients.

Published Date: 26 Apr 2023

Many women may be wondering what this means for them in light of the Supreme Court's decision on Friday regarding a crucial medication used in medical abortions.

Read Full News

Todays Updates


Worsening Heart-Kidney-Metabolic Health May Threaten Vision


People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk


Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Study Maps Extensive Disease Links Beyond Childhood Eczema


Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis


In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care


The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Two Biologics Show Comparable Benefit in Uveitis


Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk


Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

Todays Updates


Worsening Heart-Kidney-Metabolic Health May Threaten Vision


People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk


Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Study Maps Extensive Disease Links Beyond Childhood Eczema


Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis


In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care


The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Two Biologics Show Comparable Benefit in Uveitis


Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk


Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

2.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

3.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

4.

Cancer mortality continuing to decline, says report

5.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot